Sysmex Corporation (TYO:6869)
Japan
· Delayed Price · Currency is JPY | Market Cap | 909.55B |
| Revenue (ttm) | 498.69B |
| Net Income (ttm) | 46.69B |
| Shares Out | 623.62M |
| EPS (ttm) | 74.85 |
| PE Ratio | 19.48 |
| Forward PE | 17.17 |
| Dividend | 36.00 (2.42%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 3,187,900 |
| Average Volume | 3,887,005 |
| Open | 1,476.50 |
| Previous Close | 1,486.00 |
| Day's Range | 1,451.00 - 1,484.50 |
| 52-Week Range | 1,435.00 - 3,217.00 |
| Beta | 0.73 |
| RSI | 31.78 |
| Earnings Date | Feb 12, 2026 |
About Sysmex
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte co... [Read more]
Financial Performance
In 2024, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.
Financial StatementsNews
Sysmex reports 1H results
Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors
Invesco International Small-Mid Company Fund outperformed most in the real estate and consumer staples sectors due to stock selection. The fund's underweight in real estate also added to relative retu...
Sysmex H1 Profit Declines
(RTTNews) - Sysmex Corporation reported that its first half profit attributable to owners of the parent was 19.0 billion yen, a decline of 26.9% from prior year. Earnings per share was 30.50 yen compa...
Sysmex Unveils 2 Immunoassay Panels For Early Diagnosis Of Primary Aldosteronism In Japan
(RTTNews) - Sysmex Corporation (SSMXY.PK,6869.T), a diagnostic instruments, reagents and software manufacturer, on Tuesday announced that it launched the HISCL Aldosterone Assay Kit and the HISCL Reni...
Sysmex Corporation (SSMXY) Q1 2026 Earnings Call Transcript
Sysmex reports FQ1 results
Sysmex (SSMXY) reports FQ1 results: Net sales down 5.6%, operating profit drops 36.5%, and attributable profit declines 58.7%.
Sysmex GAAP EPS of Yen 86.05, revenue of Yen 508.6B
Sysmex reports 9M results
Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B
Sysmex (SSMXY) reports a strong 1H performance with GAAP EPS of ¥41.70 and revenue of ¥242.48B, an impressive 14.0% increase year-over-year.